University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Masters Theses

Dissertations and Theses

December 2020

Mitigation of Teratogenic Agents: Is There Promise in Ion
Modulating Drugs?
Aastha Pokharel
University of Massachusetts Amherst

Follow this and additional works at: https://scholarworks.umass.edu/masters_theses_2
Part of the Environmental Public Health Commons

Recommended Citation
Pokharel, Aastha, "Mitigation of Teratogenic Agents: Is There Promise in Ion Modulating Drugs?" (2020).
Masters Theses. 984.
https://doi.org/10.7275/17648171 https://scholarworks.umass.edu/masters_theses_2/984

This Open Access Thesis is brought to you for free and open access by the Dissertations and Theses at
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Masters Theses by an authorized
administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

MITIGATION OF TERATOGENIC AGENTS: IS THERE PROMISE IN ION MODULATING
DRUGS?

A Thesis Presented
By
AASTHA POKHAREL

Submitted to the Graduate School of the
University of Massachusetts in partial fulfillment
of the requirements for the degree of

MASTER OF SCIENCE
September 2020
Public Health
Environmental Health Sciences

© Copyrighted by Aastha Pokharel 2020
All rights reserved.

MITIGATION OF TERATOGENIC AGENTS: IS THERE PROMISE IN ION MODULATING
DRUGS?

A Thesis Presented
By
AASTHA POKHAREL

Approved as to style and content by:
__________________________________________________________
Laura N. Vandenberg, Chair
__________________________________________________________
Alicia R. Timme- Laragy, Member
___________________________________________________________
Timothy E. Ford, Member
________________________________________________
Laura N. Vandenberg, Graduate Program Director
________________________________________________
Timothy E. Ford, Department Chair, Environmental Health Science

DEDICATION
To my parents, for their unwavering support and love.

ACKNOWLEDGEMENTS
I would like to acknowledge and take a moment to thank all those who supported me with my
graduate thesis. To my mentor, I express the deepest gratitude for providing me with the
scientific knowledge, confidence, and inspiration that has transformed me in these past few
years, both as a researcher and as a person. I am very thankful for my two committee members,
Alicia Timme- Laragy and Timothy Ford, for your time and advice during this process. I also
want to pay my special regards to my lab members, both former and current. Thank you for
being such a great and engaging community- I have learned a lot from every single one of you. I
also would like to acknowledge the School of Public Health and the Department of
Environmental Health Sciences. Lastly, the deepest of thanks to my friends and family for
offering support and words of encouragement for my work.

v

ABSTRACT
MITIGATION OF TERATOGENIC AGENTS: IS THERE PROMISE IN ION
MODULATING DRUGS?
September 2020
AASTHA POKHAREL, B.S. PUBLIC HEALTH SCIENCES, B.S. BIOCHEMISTRY
AND MOLECULAR BIOLOGY, UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Laura N. Vandeberg
As reported by the CDC, birth defects remain a common occurrence in the United States, with
malformations originating in many places in the developing organism. Furthermore, the etiology
of many of these defects remain unknown, with some factors consisting of genetics,
environmental pollutants and teratogens. In our study, we examined whether insults by
teratogenic agents, ethanol in particular, can be mitigated by hyperpolarizing agents acting to
restore the cell’s potential. We first evaluated whether three hyperpolarizing drugs (Lamotrigine,
Gabapentin, and Ivermectin) induced teratogenic effects on CD-1 mice and found that
Ivermectin induced craniofacial malformations, and exposure to Lamotrigine and Gabpentin
resulted in limb defects in the offspring. For the second part of our study, pregnant CD-1 mice
were orally dosed with Lamotrigine or Gabapentin from gestational day (GD) 0 till parturition.
On GD 8, we exposed females to one hit of ethanol, creating four treatment groups: Vehicle,
EtOH only, Lamotrigine + EtOH and Gabapentin + EtOH. We evaluated a variety of different
endpoints: gestational outcomes, maternal outcomes, neonatal outcomes, behavioral outcomes in
pups at prepuberty, and changes in brain weight, shape, and morphology. We observed that both
vi

Gabapentin and Lamotrigine, although in varied ways, mitigate some of the perturbations
resulting from ethanol, but not all. Our study provides a preliminary, but insightful, look into the
role of hyperpolarizing agents on teratogenic insults induced by ethanol. It highlights the future
directions of research which include, but are not limited to, understanding the mode of action
through which teratogens alter individual cell behavior and the interactions between
hyperpolarizing agents on the cell’s potential when this alteration occurs.
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CHAPTER 1
BACKGROUND
Introduction
Voltage- gated channels are often studied in the context of neurons and the propagation
of action potentials; these channels are essential to the ability of neurons to communicate through
responses to stimuli. Voltage- gated channels have also been studied in the context of the cardiac
conduction system, where specialized cells known as pacemaker cells propagate a signal down
the sinoatrial node, leading to the contraction of ventricles in the heart 1. However, the role of
bioelectric signaling in the health and function of organs and organisms expands beyond just
these two examples. In fact, all cells respond to changes in voltage potential, although these
modifications in membrane voltage are usually significantly slower than those seen in neurons.
These changes to the membrane potential can impact the cell behavior and functionality; they
function to transmit information for a cell about its cell type, provide positional information of
organs, and establish the cell’s identity and aspects of tissue patterning2. In addition to these
roles, bioelectric signaling also encompasses cell- to- cell communication through electrical
conduits in the form of gap junctions3. Gap junctions allow for cells to send electrical signals to
each other (by changing the flow of charged ions) and establish gradients that span relatively
large distances, allowing networks of cells to form with similar resting membrane potentials.
Differences across different networks of cells can produce changes in pattern and spatial
orientation during development3.
These mechanisms have been well studied in the flatworm model, planaria. This model
is unique in its ability to regenerate parts of the body that have been amputated; remarkably the
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regeneration results in correct formation and position of organs as in the original worm4.
Recently, researchers studying bioelectric signaling manipulated the bioelectrical properties of
the cells during regeneration (using pharmacological treatments that affect gap junctions) and
demonstrated that these bioelectrical manipulations produced altered anterior- to- posterior
polarity within the flatworm5. By suppressing gap junctions, deformities such as the development
of two heads instead of a normal head- to- tail body5. These studies confirmed the importance of
bioelectric signaling in tissue patterning, on the scale of whole organs. Similar effects have been
observed in Xenopus frogs; alterations of bioelectrical properties, through treatments with
pharmaceuticals or with molecular genetic tools (e.g., expression of dominant negative ion
channels) prevented the normal regeneration of the Xenopus tadpole tail.6 Limb development
was induced in adult Xenopus, a time when regeneration is not naturally observed, by
manipulating the bioelectrical environment after amputation7 . These results suggest that
bioelectrical signaling may play a role in large-scale patterning of the body plan and organs in
other organisms. However, studies examining these events in mammals have been lacking,
making it difficult to translate these results to humans.
During development, cell behaviors drive the formation of organized structures and
tissues that require proper patterning. One of the best studied examples is the developing
drosophila embryo, which segregates morphogens to the anterior- and posterior-most poles of the
embryo, creating unique gene expression cascades along the anterior-posterior axis8 . It has been
proposed that bioelectrical signaling can similarly create tissue patterns; for example,
Vandenberg et al. demonstrated that bioelectrical membrane voltage domains mark areas of the
Xenopus embryo where cells change shape, creating a pre-pattern of craniofacial structures prior
to the expression of master genes such as Pax69 .
2

Due to their ability to create complex structures and modulate cell behavior through
changes in membrane potentials, alterations of bioelectrical signaling may also be induced by
environmental insults during development. Such disruptions are predicted to ultimately lead to
birth defects and altered organ function2. Teratogens are environmental agents that alter
embryonic or fetal development and induce birth defects that can alter the quality of the
organism’s life forever. Agents such as teratogens have the ability to move the cell to an
abnormal bioelectrical state, such as a relatively depolarized membrane potential, that can then
disrupt normal downstream signals (e.g., cell-cell communication, or subsequent gene
expression) and disrupt proper formation of tissues within the developing organism.
HCN2 Overexpression Rescues Nicotine- Induced Effects in Xenopus
In the US, every 4.5 minutes, a baby is born with birth defects10 . These malformations
can occur anywhere in the body. Many risk factors associated with these birth defects, as noted
by the US Centers for Disease Control and Prevention (CDC), include exposure to teratogens
such as nicotine, alcohol, drugs, or other environmental agents 10. The harmful effects of nicotine
and alcohol on the fetus are especially well- studied. Both of these agents are known to
depolarize cells, as they shift the cell’s membrane potential to a depolarizing state and ultimately
disrupt normal patterning of tissues. This mechanism of teratogenic agents begs another
question: can hyperpolarizing reagents mitigate insults made by teratogens by modulating the
membrane potential back to its natural state?
One recent study conducted by our collaborators at Tufts University used an amphibian
model to study the teratogenic effects of nicotine. This neuroteratogen is known to cause many
morphological malformations in the brain and developing craniofacial structures; exposure to
nicotine during fetal development can also impair cognitive function in children. As expected,
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these effects were recapitulated in Xenopus tadpoles11 . Remarkably, overexpression of HCN2, a
hyperpolarizing activated cyclic nucleotide-gated channel, completely rescued the morphological
and behavioral deficits associated with nicotine exposure. HCN2 is a voltage gated channel that
controls neuron excitability and is especially important in the spontaneous electrical activity of
the heart and modulating synaptic transmissions in the brain12 . Further, this channel also plays a
role in the normal patterning of the Xenopus embryo including development of the brain.
How might overexpression of HCN2 rescue the teratogenic effects of nicotine? Our
colleagues demonstrated that nicotine depolarizes cells in the developing brain and craniofacial
structures during embryonic development11 . However, in the presence of HCN2, a competing
hyperpolarization occurs, returning the cells of the developing embryo back to their typical
bioelectric state11. HCN2 overexpression led to the correct formation of the brain, which was
also proportional in size to surrounding tissues11. These results support the hypothesis that
reagents that normalize perturbations in bioelectric signaling can mitigate teratogenic insults
during embryonic development and induce normal development of tissues.
Study Objectives
My Master’s thesis aims to understand the interaction between ion modulating drugs and
alcohol, a classical teratogen. Specifically, we ask whether hyperpolarizing agents can block the
effects of alcohol in the CD-1 mouse. The perturbations induced by alcohol in the human have
been extensively documented, with effects ranging from reduced cognition function to congenital
malformations of the face, heart, and brain13-15 . In mice, exposure to alcohol results in decreased
litter size, decreased pup size/weight, disruptions in brain and spinal morphology, malformations
of the craniofacial structures, and fetal resorptions (e.g., the rodent equivalent of miscarriage,
absent the expulsion of the embryo/fetus)16 . We hypothesize that effects of prenatal ethanol
4

exposure will be mitigated by administration of the two hyperpolarizing drugs, Lamotrigine and
Gabapentin, as shown by the testable model in Figure 1.2.

Lamotrigine

Ethanol

Nicotine

v

v

Gabapentin

Ivermectin

Figure 1.1 Chemical structures of Ethanol, Nicotine, Lamotrigine, Gabapentin and
Ivermectin

Figure 1.2 Testable model for mitigation of prenatal ethanol exposure by hyperpolarizing
drugs
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Pharmacokinetics and Mode of Action of Lamotrigine
In order to address these questions, three hyperpolarizing drugs were evaluated. The first
is Lamotrigine, a phenyltriazine derivative that is most commonly prescribed to patients as an
anticonvulsant17. As an anticonvulsant, it is most often prescribed to treat secondary generalized
seizures and complex partial seizures18. Lamotrigine is an electroneutral molecule, with nonionizable polar groups at one end and an aromatic moiety on the other end17. Like some other
antiepileptic medicines, Lamotrigine functions by blocking voltage-gated sodium channels (NaV)
which subsequently blocks the release of excitatory neurotransmitters such as glutamate and
aspartate19. Nav channels lead the induction and conduction of action potentials in a variety of
excitable cells including skeletal and cardiac muscle cells and neurons. These channels are
naturally found in one of three states: closed, inactivated or activated. When the cell is at a
negative resting potential, the channel is in a closed position, where it stays until induced by a
stimulus20. When a cell receives a stimulus from a neighboring cell, Nav channels open and lead
to quick depolarization of the cell, which places the cell in an activated state. In order for an
action potential to propagate throughout the cell, it must cross a critical threshold of membrane
voltage, producing the action potential itself. The inactive state of the channels are observed after
the action potential, during a refractory period when the channels close and structurally change.
This change prevents the cell from being excited by a stimulus from a neighboring cell.
Hyperpolarization of the cell also occurs when potassium channels open up and potassium ions
exit the cell, decreasing the overall voltage of the cell. Lamotrigine selectively binds to Nav
channels in their inactivated state; this binding suppresses the flow of sodium currents and thus
stabilizes the presynaptic neuronal membrane19,21.
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Aside from the brain, Lamotrigine can produce off-target effects in the heart, where
cardiac muscle cells are similarly sensitive to bioelectrical currents produced by voltage-gated
sodium channels and potassium channels. The effects of Lamotrigine relate directly to the QRS
complex, which is a graphical representation of the ventricular depolarization of the heart and is
represented by 5 separate waves, PQRST. The P wave signifies atrial depolarization, which is
triggered by the SA node22. The next three waves are typically referred to as the QRS complex
and signify ventricular depolarization of the heart22. Shortly after the depolarization,
repolarization occurs during the T wave22. The effects of Lamotrigine on this complex occur
through the 2-N-glucuronide conjugate which makes up 70% of Lamotrigine’s metabolites in
humans23. The drug prolonges the PR interval and widens the QRS complex23. With a high
enough dose, these changes can lead to the ultimate blocking of AV conduction23.

Figure 1.3. Schematic of the QRS complex
In humans, Lamotrigine is absorbed almost completely, with 98% absolute
bioavailability24. In one study, healthy volunteers were dosed orally with one single dose of
radioactive Lamotrigine, and maximal serum concentration of the drug was seen at 2.8 hours +/1.3 hours (Beattie et al., 2012). Lamotrigine does not follow first pass metabolism through the
liver24. Instead, Lamotrigine has a wide and uniform distribution and including relatively strong
plasma protein binding ability 17. Lamotrigine is mostly metabolized through
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glucuronosyltransferase (UGT) at the N-2 position 25. The glucuronidation of LAMOTRIGINE
in humans results in the metabolite, 2-N-glucuronide conjugate, which accounts for 90% of
metabolites25. The presence of food does not affect its metabolism. 70% of the drug is eliminated
within 144 hours, and the half-life of Lamotrigine is 24.1 to 35 hours 17.
Lamotrigine has become increasingly popular as a treatment for pregnant women with
epilepsy because the incidence of birth defects is lower with this drug compared to alternatives26
. However, there are conflicting studies about Lamotrigine’s role as a teratogen. Lamotrigine has
the ability to cross across the placenta, and thus, maternal treatment with this drug also means
fetal exposure27. In a study conducted in rats, researchers examined effects of Lamotrigine
during pregnancy. Results indicated that, compared to controls, treated dams experienced
significantly less weight gain during pregnancy and also a significant decrease in the mean
number of pups per litter 27. In addition, pups from the treated mothers also experienced a
decrease in body weight at parturition 27. In conclusion, although human effects of this drug as a
teratogen have been inconclusive, animal data provide some indication that Lamotrigine may be
fetotoxic.
Pharmacokinetics and Mode of Action of Gabapentin
The second drug we have considered is Gabapentin, which was approved by the Food
and Drug Administration (FDA) in 1993 as treatment for epilepsy and, subsequently, as an
analgesic for post-herpetic neuralgia in 2004. Structurally Gabapentin resembles the inhibitory
neurotransmitter, GABA; however, the drug’s mode of action does not modify or alter GABA in
any way28. Studies conducted in rodents indicate that gabapentin binds the auxiliary subunits of
voltage-gated calcium (CaV) channels in the neocortex and hippocampus28. In these locations,
Gabapentin attenuates the channels, preventing depolarization 25. CaV channels are multi- subunit
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complexes, which work in a similar fashion to NaV channels, where they induce depolarization
of the cell after a stimulus. CaV channels have functions in many different cell processes, ranging
from excitation- contraction coupling, neurotransmitter release, regulation of gene expression
and neuronal migration29. The channels are comprised of four subunits: α1, α2δ, β and γ 30. The
α1 is the pore of the calcium channel, which is trafficked by the α2δ-1 to increase binding sites
for ligands30. α2δ-1 also plays a key role in increasing the amplitude of the current of the
channel, has fast activation/inactivation kinetics, and depends on cell voltage to be activated25.
α2δ-2, the other component of the subunit, plays a key role in increasing the amplitude of the
channel in the same fashion as its counterpart, α2δ-125. These two auxiliary subunits are the
binding sites for a group of drugs known as gabapentinoids. Prior research indicates that this
class of therapeutic drugs, which includes gabapentin, provides analgesic benefits by binding to
these subunits.
A disease that is related to mutations in CaV channels is epilepsy and this has been
studied through a mutant mouse strain, Ducky. The Ducky mutation induces cerebellar ataxia,
absence epilepsy and demyelination of the hindbrain and spinal cord30. Upon further
investigation, researchers identified the mutant allele in this mouse strain to be within the α2δ- 2,
which is truncated and, therefore, displays aberrant function30. In addition to epilepsy, these
channels are also associated with neuropathic pain. Upregulation of both subunits results in
allodynia, which leads to a pain response from stimuli that do not normally provoke such a
response31. Experiments show that there is an upregulation of mRNA and protein in the dorsal
root ganglion neurons and spinal cord on the same side as an experimental nerve crush injury30.
Binding of gabapentin to the subunits reverses allodynia through gabapentin- mediated inhibition
of calcium current. The proposed mechanism of action of gabapentin on voltage gated calcium
9

channels both indicate and reaffirm gabapentin’s potential as adjunctive therapy for epilepsy and
treatment for neuropathic pain31.
In humans, gabapentin is absorbed in the proximal portion of the small intestine and
transported into the blood stream by the L-amino acid transport system32 32. The bioavailability
of the drug in the body is dose- dependent. Peak concentrations in the body are usually seen 1 to
2 hours post oral administration32. The drug is not easily bound to plasma protein and is readily
excreted via the renal pathway in its original form. The half- life of gabapentin is only 5 to 7
hours32. The clearance of the drug from the body is parallel to creatinine clearance in the body.
Renal clearance is decreased in elderly patients and those who may suffer from a renal
abnormality33.
The most common reported side effect of gabapentin is accumulation of the drug in the
cerebrospinal fluid and neurotoxicity due to the drug’s hydrophobic characteristics, which allow
for it to diffuse across adipose cells and cell membranes33. Animal studies also show that
gabapentin induces proliferation of pancreatic acinar cells34. In rodents, gabapentin induced
pancreatic acinar tumors; however, the mechanism through which this occurs remains to be
studied. One proposed hypothesis relies on the relationship between gabapentin and calcium
channels. Proliferation in pancreatic cells requires the influx of calcium, which may be
inappropriately induced by gabapentin 34. Further studies are needed to confirm this link between
the pancreatic acinar cell proliferation and altered CaV activity. In humans, high doses of the
drug and diminished renal function may lead to drastic effects such as hypoglycemia33.
A third pharmaceutical, ivermectin, was also selected for our studies. Like Lamotrigine
and gabapentin, ivermectin hyperpolarizes cells. However, its mechanism is distinct; it opens
chloride channels, depressing the central nervous system by potentiating inhibitory GABA-ergic
10

neurons35 . Ivermectin is widely used as an anti-nematode drug in the treatment of river
blindness, eyeworm, and threadworm as well as head lice and scabies36 .
Objective of Following Chapters
Due to the possible off- target effects of both of these drugs, a preliminary study was
conducted on hyperpolarizing agents in order to determine their teratogenicity. CD-1 mice were
administered one of three hyperpolarizing agent: lamotrigine, gabapentin, and ivermectin. On
gestational day 17, fetuses were collected from these dams and the effects of the drugs were
examined. We examined multiple endpoints, like litter size/ weight, fetal growth parameters, and
limb and craniofacial defects. In Chapter 2, I will detail the results of this pilot study which
determined that only two hyperpolarizing agents (Lamotrigine and gabapentin) were appropriate
for future studies. In Chapter 3, I present the data I collected on the mitigating effects (or absence
of mitigating effects) of hyperpolarizing drugs in pregnant mice exposed to alcohol, a teratogenic
insult. Finally, in the last chapter, I provide a brief discussion on the implications of the results of
our study and future directions.
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CHAPTER 2
POTENTIAL TERATOGENIC EFFECTS OF HYPERPOLARIZING AGENTS
Abstract
Recent studies suggest that molecular reagents that hyperpolarize cells of the embryo can interfere
with teratogenic agents in Xenopus. Before these experiments can be validated in mammals, data
are needed to determine if pharmaceuticals that act as hyperpolarizing agents are also
teratogenic. Three hyperpolarizing agents, lamotrigine, gabapentin, or ivermectin, were
administered to CD-1 mice throughout pregnancy. On pregnancy day 17, foetuses were collected,
weighed individually, and examined for deformities and defects. Reported here are data on the
effects of these three hyperpolarizing agents on litter size, litter weight, individual foetal weight,
and foetal growth parameters including crown-to-rump body length and the distance between the
eyes. Each foetus was also examined for limb defects, craniofacial defects, and abnormal
hematomas and foetal resorptions, including partial resorptions, were also noted. These data
indicate no relationship between treatment and litter size or litter weight. However, there was a
negative association between litter size and foetal body weight in control litters, but these
associations were diminished in all three drug-treated groups. Additional data suggest that
lamotrigine and gabapentin may increase the incidence of limb deformities and ivermectin may
increase cranial defects.

Keywords
Growth restriction; ion channel; limb defect; craniofacial; in utero resorption; litter size
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Specifications Table
Table 2.1. Summary of study design, data description and collection for examining activity
of hyperpolarizing agents
Subject

Health, Toxicology, and Mutagenesis

Specific subject area

Developmental toxicology

Type of data

Graphs illustrating the number of foetuses per litter, the weight of
the litter, and the relationship between litter size and foetal weight

Graphs illustrating growth parameters in foetuses.

Images illustrating how growth parameters were measured.

Table of the number of pups, and number of litters, affected by
different types of deformities.

Images illustrating foetal deformities.
How data were

Analytical balance

acquired

Zeiss AxioImager dissection microscope, Zeiss high resolution
colour camera, and ZEN software
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The animals were maintained at the University of Massachusetts,
Amherst Animal Facility in temperature and light controlled
conditions. All experimental procedures were approved by the
University of Massachusetts Institutional Animal Care and Use
Committee.
Data format

Primary (raw) data, quantified and analysed graphs

Parameters for data

Exposure of pregnant female CD-1 mice throughout pregnancy to

collection

25 mg/kg/d lamotrigine or gabapentin, or 0.25 mg/kg/d ivermectin;
oral route of exposure. Foetuses collected and individually weighed
on gestational day 18. After fixation, foetuses were inspected for
defects via dissection microscope. Foetal growth parameters
measured with dissection microscope and ZEN analytical software.

Description of data

Gestational day 18 foetuses were removed from the amniotic sac,

collection

blotted dry and weighed. All foetuses were examined at the time of
collection, then fixed in neutral buffered formalin and examined
again using a dissection microscope.
Comparisons were made between control litters and each treatment
group. Outcomes collected for evaluation include number of
foetuses per litter, weight of individual foetuses, total weight of the
litter, incidence of limb and craniofacial defects, incidence of foetal
resorptions, and growth parameters of the foetuses (body length and
distance between the eyes).

14

Data source location

Institution: University of Massachusetts Amherst
City/Town/Region: Amherst, MA
Country: USA

Data accessibility

Value of the Data

•

These data are useful because they help to address conflicting findings from previous
studies about the teratogenic effects of ion channel modulators.

•

These data are useful to developmental toxicologists and researchers interested in
modulating the activities of ion channels in mammals or other model species. These data
may also provide potential benefit to clinicians that prescribe lamotrigine, gabapentin, or
ivermectin to patients as pharmaceutical interventions.

•

These data provide insights into the range of outcomes that can be affected during
prenatal development when ion channel activity is disrupted. They also provide
information about how whole-body hyperpolarization might be useful for the treatment of
congenital defects and developmental disorders.

•

These data provide researchers with background rates of deformities and growth
parameters in wildtype CD-1 mice, which may be useful in future studies of teratogenic
agents.
15

Results
Data
Prior studies in Xenopus laevis have demonstrated that exposures to hyperpolarizing agents
during embryogenesis induce developmental malformations including malformations of the head
and brain37 . Yet, molecular genetic manipulations that cause hyperpolarization of a subset of
embryonic cells are also sufficient to rescue chemical-induced teratogenesis11. Data are needed
to evaluate the effects of global hyperpolarization on mammalian embryos, and determine if
hyperpolarization can interfere with teratogens in these species.

To determine whether hyperpolarizing drugs gabapentin, lamotrigine or ivermectin disrupt
growth in utero, we exposed pregnant mice orally to one of these drugs or a vehicle control. On
gestational day 18, foetuses were delivered by Caesarean section, counted, weighed, and
inspected individually. There were no significant effects of gabapentin, lamotrigine, or
ivermectin on the number of foetuses per litter (Figure 2.1A) or the total litter weight (Figure
2.1B).

Prior studies suggest a negative association between the number of animals in the litter and body
weight of individual rodent pups38 . When individual foetal weight was compared to litter size, in
controls, a negative association was observed (R2=0.29, Figure 1C). In all three drug treatment
groups, the correlation between litter size and body weight was much weaker (R2 values ranging
from 0.01-0.10).
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Figure 2.1. Exposure to ion modulating drugs does not alter litter size or
litter weight, but disrupts the relationship between litter size and individual
pup size. A) Average litter size was not significantly different between controls
and any of the drug treated groups. B) Average litter weight was not significantly
different between controls and any of the drug treated groups. C) In controls,
there was a modestly strong linear association between litter size and the weight
of individual pups, as has been described previously (R2=0.2942). The strength of
this association was much lower in all three of the treated groups (R2 <0.1). In
panels A and B, litter sizes are: controls = 8; gabapentin = 12; ivermectin = 8;
lamotrigine = 11. Data represent mean ± standard error. In panel C, sample sizes
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(individual foetuses) are: controls = 96; gabapentin = 141; ivermectin = 93;
lamotrigine = 115

To determine if gestational exposure to ion modulating drugs affected foetal growth, we next
measured parameters of body size including crown-to-rump distance (Figure 2.2A), a measure of
body length, and distance between the eyes (Figure 2.2B), a measure of head size. Both of these
measures are known to be affected by different teratogenic agents. We observed no effect of
gabapentin, ivermectin, or lamotrigine on either of these growth parameters (Figure 2.2C, D).

Figure 2.2. Gestational exposure to hyperpolarizing agents has no significant
effect on foetal growth parameters. A) Lateral view of a control foetus on
gestational day 17. The crown-to-rump measurement is illustrated in this view.
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Scale bar = 2 mm. B) Frontal view of a control foetus on gestational day 18. The
distance between the eyes is illustrated in this view. Scale bar = 2 mm. C)
Quantification of body length revealed no effect of treatment group. D) Distance
between the eyes was also not affected by treatment group.

To determine if exposure to hyperpolarizing agents increases the incidence of severe deformities,
each foetus was examined for limb and craniofacial malformations. Limb deformities were never
observed in control litters (Table 2.1), consistent with our prior experience evaluating control
foetuses in CD-1 mice. Litter defects were observed in 2 foetuses exposed to gabapentin (from 2
different litters), and 1 foetus exposed to lamotrigine (see examples, Figure 2.3A). Cranial
defects were rare in control litters (Table 2.1), also consistent with our prior experience
evaluating control foetuses in CD-1 mice. Cranial defects were also observed in 2 foetuses (from
one litter) exposed to lamotrigine, and 4 foetuses exposed to ivermectin (from 2 different litters)
(see examples, Figure 2.3B).

As we were delivering each foetus via Caesarean section, we also noted the presence of partially
or fully resorbed foetuses, indicative of death in utero. Five resorptions were noted in 2 control
litters (Table 2.1). Resorptions were not observed in gabapentin or ivermectin treated litters;
three resorptions in 2 lamotrigine-treated litters were observed (see examples, Figure 2.3C).

Finally, other defects observed in all treatment groups included haematoma bands (see examples,
Figure 2.3D). Haematomas were observed in 1 control foetus, 3 gabapentin treated foetuses
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(from 3 different litters), 1 ivermectin treated foetus, and 3 lamotrigine treated foetuses (from 2
different litters) (Table 2.1).

Table 2.2. Summary of defects observed in foetuses from litters exposed to hyperpolarizing
agents
Limb defectsa

Cranial defectsa

Resorptionsa

Haematomasa

0

1/96 [1/8]

5/96 [2/8]

1/96 [1/8]

Gabapentin

2/141 [2/12]

0

0

3/141 [3/12]

Ivermectin

0

4/93 [2/8]

0

1/93 [1/8]

1/115 [1/11]

2/115 [1/11]

3/115 [2/11]

3/115 [2/11]

Litter
treatment
Control

Lamotrigine
a

Numbers indicate affected pups, numbers in brackets are affected litters
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Figure 2.3. Gestational exposure to hyperpolarizing agents and
developmental defects. A) Examples of limb defects; arrows indicate
malformations. B) Examples of cranial defects. C) Example of a foetal resorption,
which indicates foetal death. D) Example of a haematoma band. In all images,
treatment of the foetus is indicated; scale bar = 2 mm.

Methods and Study Design

Experimental Design, Materials, and Methods
Animal husbandry and necropsy
Pregnant female CD-1 mice (Charles River Laboratories, Raleigh, NC) were housed in
polysulfone cages with tap water and rodent chow (ProLab IsoDiet, Brentwood, MO) provided
ad libitum. Animals were maintained at the University of Massachusetts, Amherst Central
Animal Facility, in temperature- and light-controlled conditions (12-hour cycles of light and
dark). All experimental procedures were approved by the University of Massachusetts
Institutional Animal Care and Use Committee.
Females were randomly assigned to treatment groups and administered vehicle (60% saline/40%
DMSO) or one of three pharmaceuticals throughout the entirety of pregnancy. Pharmaceuticals
included lamotrigine (administered at 25 mg/kg/day), gabapentin (administered at 25
mg/kg/day), and ivermectin (administered at 0.25 mg/kg/day). These drugs were selected
because they are hyperpolarizing agents, and doses were selected based on prior toxicity studies
(gabapentin39, ivermectin40, lamotrigine41). Doses were adjusted daily for body weight and
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animals were administered pharmaceuticals in vehicle in a volume of 2.5 µl per gram body
weight per day.
Sample sizes were control = 8 litters, gabapentin = 12 litters, ivermectin = 8 litters, lamotrigine =
11 litters. These sample sizes were selected based on prior studies39-41 .
Pregnant female mice were euthanized on pregnancy day 18 by CO2 asphyxiation, followed by
decapitation. Foetuses were delivered individually by Caesarean method, and extraembryonic
tissues were removed. After blotting excess amniotic fluid, each foetus was weighed, examined
for gross malformations, and then fixed in neutral buffered formalin.
Measurements of body size
Digital images of individual foetuses were obtained using a Zeiss AxioImager dissection
microscope (Carl Zeiss Microscopy, Jena, Germany) and a Zeiss high-resolution color camera.
Each individual foetus was examined for limb and craniofacial defects. Haematoma bands were
recorded when observed. Body length, e.g., the distance from the top of the cranium to the rump,
and distance between the eyes were both measured using ZEN software (Zeiss).
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CHAPTER 3
PRENATAL EXPOSURE TO ETHANOL AND RESPONSE OF HYPERPOLARIZING
AGENTS TO PERTURBATIONS
Introduction
According to the US Center for Disease Control and Prevention (CDC), birth defects affect one
in every 33 babies born in the United States10. Virtually any organ of the body can be affected by
congenital malformations, and depending on the severity of the defect, the long-term quality of
life of the child, and even lifespan, can be affected. For most birth defects, the cause is unknown,
although the US CDC notes that several features increase the risk that a woman might have a
pregnancy associated with these defects, including smoking and drinking alcohol; use of other
drugs; uncontrolled diabetes during pregnancy; use of certain pharmaceuticals; having a family
member with a birth defect; or being an older mother.
There is some evidence that genetic factors can contribute to disruptions during embryogenesis
that could result in developmental delays and congenital malformations. Spina bifida is a neural
tube defect, where the cranial region of the neural tube fails to fuse with the spinal region,
creating an open dysraphism42 . Although the survival rate for spina bifida has jumped 40% from
the 1970s, patients with this condition experience many complications in their daily lives43.These
complications range from chronic incontinence to reproductive irregularities and orthopedic
problems43 . Studies indicate that this birth defect is associated with mutations in the VANGL1
gene which can lead to partial or complete loss-of-function of this gene42 . VANGL1 is a planar
cell polarity protein gene which plays a key role in mediating convergent extension, a necessary
process for neural tube closure42 . The VANGL1 gene is just one of several that have been
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implicated in severe birth defects and serves as a model for the study of other embryonic
patterning genes involved in embryonic and fetal malformations.
There are estimates that exposures to environmental teratogens during the normal course of
gestation account for 10-12% of all birth defects44 . Thus, exposures to environmental pollutants
have increasingly received attention from scientists and public health officials, because these
agents can induce malformations that become apparent near the time of birth as well as increase
the likelihood of developing later-life diseases45 . Arsenic, for example, is a chemical that can be
found around the world in drinking water. In some countries, such as Bangladesh, children are
born with arsenic concentrations that are as high as what their mothers experience during
pregnancy46 . This is because the placental barrier is permeable to arsenic, and in utero exposures
induce cellular responses such as inflammation, cell death, and stress, which alter development
of the fetus46 . Fetal arsenic exposure has been shown to lead to altered pulmonary function47,48
and increased risk of acute myocardial infarction49 in adulthood.
Alcohol is another known teratogenic agent. The general public currently has a good
understanding of the effects of alcohol intake during pregnancy; public health advocates have
worked to ensure that people understand that there are risks associated with fetal alcohol
exposure. Despite public education programs and interventions in place, use of alcohol during
pregnancy among women remains high and has steadily increased in the United States from 2006
to 201750 .The US CDC issued surveys between the years of 2015-2017 to examine alcohol
drinking prevalence among pregnant women. Their results indicated that 11.5% of participants
from a representative sample of 6,814 pregnant women reported casual drinking during their
pregnancies51 . Additionally, 3.9% reported binge drinking, and risk of this behavior was
significantly increased in non-married women compared to married women51 . Compounding
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this fact, almost half of the pregnancies that occur in North America are unplanned, and social
drinking is common among many women52 . These two factors greatly increase the risk of
exposure to alcohol in early gestation, when a woman might not even be aware of her pregnancy
status.
In 1981, the US Surgeon General officially issued its first public health advisory on the harmful
effects of alcohol on the developing fetus. Guidelines for diagnosis of disorders associated with
alcohol exposure during gestation were not written until almost a decade later. Now, there is a
blanket term for defects that are associated with alcohol consumption: fetal alcohol syndrome
disorders (FASDs). The effects of FASDs span beyond just physical malformations and take into
account behavioral, mental, and learning deficits as well52 . In 1996, diagnosis of FASDs was
outlined by the Institute of Medicine; these guidelines highlighted that if no maternal alcohol
consumption can be proven, diagnosis of FASD can only occur when facial defects are
apparent52 . Some common effects on craniofacial structures include short palpebral fissure (the
distance between the canthus of both eyes), a smooth philtrum (the indentation between the nose
and upper lip), and thinning of the upper lip52 .
Explaining the mechanisms of how teratogens affect development is complicated because many
teratogenic compounds act through multiple molecular pathways; these pathways can
individually, or collectively, lead to a defect. Some of the molecular processes that are
implicated in teratogenic agent exposures include epigenetic modifications and altered signal
transduction leading to unusual apoptosis and disruption of tissues44 . Yet, as noted by the US
CDC, the etiology of many birth defects remains unknown. For this reason, identifying
treatments that can block, mitigate, or fix the effects of teratogenic agents is an important
research need.
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One recent study conducted by our collaborators at Tufts University used an amphibian model to
study the effects of nicotine. This neuroteratogen is known to cause many morphological
malformations within the brain and lead to impaired cognitive function in humans, and these
effects were recapitulated in Xenopus tadpoles11 . Our colleagues showed how overexpression of
HCN2, a hyperpolarizing activated cyclic nucleotide-gated channel, could completely rescue the
morphological and behavioral deficits associated with nicotine exposure. HCN2 is a voltage
gated channel that controls neuron excitability and is especially important in the spontaneous
electrical activity of the heart and modulation of synaptic transmissions in the brain12 . Yet, this
channel also plays a role in the normal patterning of the Xenopus embryo including development
of the brain.
How might overexpression of HCN2 rescue the teratogenic effects of nicotine? Our colleagues
demonstrated that nicotine reduces the membrane potential of embryonic cells through
depolarization of these developing cells11 . However, in the presence of HCN2, a counter-acting
hyperpolarization occurs, returning the cells of the developing embryo back to their typical
bioelectric state11 . HCN2 overexpression led to the correct formation of the brain, which was
also proportional in size to surrounding tissues11 . These results support the hypothesis that
reagents that normalize perturbations in bioelectric signaling can reverse teratogenic insults
during embryonic development and induce normal development of tissues.
There are several emerging hypotheses regarding the role of bioelectrical signaling on
teratogenic insults: first, because bioelectrical signals can control cell proliferation35,53 ,
differentiation54 , embryonic patterning55,56 , cell-cell communication57 , and tissue regeneration
and repair58,59 , it is plausible that many teratogenic agents disrupt bioelectrical signals. Second,
if teratogenic agents push the bioelectric properties in one direction – toward depolarization –
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then reagents that hyperpolarize embryonic cells should reverse the effects of these agents; and
conversely, teratogenic agents that hyperpolarize can be reversed by depolarizing agents.
Anticonvulsants, which are prescribed to epileptic patients, have long been correlated with
increased incidences of congenital malformations when these patients are pregnant60 . Many
antiepileptic drugs (AEDs) modulate levels of serotonin and GABA, and these neurotransmitters
actively play a role in regulating the concentration gradients of ions within cells60 . Thus,
although the specific mechanisms of action of these drugs vary, they are collectively known to
alter ion flux in cells, making them promising reagents to evaluate in the context of
teratogenesis.
Here, we ask whether hyperpolarizing agents can block the effects of alcohol, a teratogen which
is known to depolarize cells of the Xenopus embryo. Using the CD-1 mouse model, this work is
meant to extend our collaborators’ studies from Xenopus into a mammal for the first time.
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Methods
Exposure of mice to ion modulators and ethanol
Female mice were mated with untreated male CD-1 mice, and housed in a light (12 hour light, 12
hour dark), temperature, and humidity controlled facility in polysulfone cages. Food and
water was provided ad libitum, at the University of Massachusetts Amherst Animal Facility. All
experimental procedures were approved by the University of Massachusetts Institutional Animal
Care and Use Committee. Prior to mating, females were randomly assigned to one of three
treatment groups: vehicle, Lamotrigine (25 mg/kg), and Gabapentin (25mg/kg). Starting from
pregnancy day 0 till parturition, females were orally dosed by pipet with vehicle or one of the
two drugs. Doses were adjusted daily for body weight. At pregnancy day 8, half of the females
were randomly chosen for ethanol administration via intraperitoneal injection (IP
injection). Some of the dams were euthanized at pregnancy day 17. The remainder of the dams
delivered naturally; the day of parturition is designated lactational day 0 (LD 0) for the mothers
and postnatal day 0 for the pups.
Fetal Necropsies
On pregnancy day 17, one set of pregnant females (n=8 per treatment group) was euthanized by
CO2 asphyxiation. The uterus was dissected and individual fetuses were removed, cleaned of
amniotic fluid and extraembryonic membranes, dried, and weighed on an analytical balance.
Each fetus was examined for gross morphological defects and then fixed in neutral buffered
formalin. After fixation, pups were imaged using a Zeiss AxioImager. Length of the body was
measured with ZEN pro imaging software. Finally, brains were dissected from the skulls and
stored in 70% ethanol for future evaluations.
Evaluation of pregnancy and postnatal outcomes
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Pregnant females were weighed every day throughout pregnancy. The time between mating plug
and parturition was recorded as gestational length. The number of pups and weight of litters were
recorded each day from LD 0 till LD 10. Dam weight was also recorded on LD 0 to account for
missing pups. On PND 10, all the pups were sexed by examining anogenital distance and the sex
ratio of each litter was recorded. On PND 14, eye- opening for the pups was observed, an
important developmental marker. Litter size and litter weight was also recorded for the last time
on PND 14.
Postnatal Necropsies
On PND21, one male and one female pup from each litter were euthanized via CO2 asphyxiation
followed by decapitation. Their brains were removed from the skull and collected in neutral
buffered formalin. Prior to decapitation, body weight was recorded, and anogenital distance was
measured using calipers. The heart was also collected during necropsy but not used in this
study.
Evaluation of brains
Fixed brains were washed with phosphate buffered saline and stored in 70% ethanol at 4C. Fetal
brain weights were recorded and digital images of the dorsal view of the brain were collected
using the Zeiss AxioObserver dissection microscope. For brains collected at PND 21, brain
weights were also calculated and digital images of dorsal view of the brains were collected using
the Zeiss AxioObserver dissection microscope.
Geometric Morphometric analyses of brains
Using digital images collected from the dissection microscope, as mentioned above, the
statistical software MorphoJ was utilized to examine the gross morphology of both the fetal and
PND21 brains. The analysis consisted of using a landmark- based morphometric analyses which
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allowed for the creation of a warped- outline diagrams, allowing for qualitative measurement of
changes in brain size and shape.
Open Field Assay
On postnatal day 22, one male and one female pup from each litter was individually placed in a
40 cm x 40 cm x 40 cm open- field apparatus. Their behaviors was observed for 5 minutes, with
blind observers scoring various measures: rearing against the walls, rearing (in the open), and
grooming events. The five minute trial was recorded using a Kodak digital camera.
Behavioral and Statistical Analysis
Ethovision XT 10 tracking software was used for analysis of the videos collected during open
field behavior assays. The video recordings were first converted into mpeg format for the
analysis of parameters including distance traveled, velocity, and movement. The distance
traveled mapped the total area in the open field chamber visited by the mice during the 5-minute
behavioral analyses. The activity of the mice was also calculated through the velocity measure.
Spatial movements of the mice were recorded to mark the active and inactive period of their
movement and their placement (at the edge, in the border region, or in the center) of the open
field apparatus.
All analyses were conducted by observers blind to the treatment groups. Data were analyzed
using SPSS Version 24. Continuous variable data were analyzed using 1-way ANOVA General
Linear Model analyses with treatment as the independent variable, followed by Fisher’s LSD
post hoc tests. Data were considered statistically significant at p<0.05. Graphs illustrate means ±
standard error unless otherwise stated.
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Results
Prenatal ethanol exposure stunts fetal growth, and this effect is not mitigated by
hyperpolarizing drugs
Pregnant mice were administered ethanol on pregnancy day 8, a period that was previously
shown to alter survival, growth and development of the exposed fetuses. Additionally, to test the
hypothesis that hyperpolarizing drugs can mitigate the effects of ethanol on fetal outcomes,
lamotrigine or gabapentin was administered to a subset of females throughout pregnancy.
First, we evaluated fetal growth outcomes in control, ethanol, and ethanol plus hyperpolarizing
drug treatment groups at GD 17. We measured fetal weight and size of all pups in each litter
delivered by Caesarean section. As expected, ethanol affected both fetal weight and body length,
with pups born from ethanol-exposed dams significantly lighter body weight and shorter body
length than what was seen in controls (Figure 3.1A, B). These effects were not mitigated by
either lamotrigine or gabapentin; pups exposed to either of the hyperpolarizing drugs plus
alcohol follow the same trend of being significantly smaller than controls in both body weight
and length.

Ethanol increases fetal death, and this effect is mitigated by gabapentin treatment
In litters delivered by Caesarean section on GD17, full resorptions were recorded when only the
placenta and yolk sac, and no fetal tissues, could be recovered. Partial resorptions included all
resorptions where some fetal development occurred but was halted early in gestation.
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As expected, the number of resorptions was significantly increased in litters treated with ethanol
compared to controls (14% resorptions in ethanol-treated litters compared to just 2% in controls,
see Figure 3.1C). Litters treated with lamotrigine + ethanol followed a similar trend, with a
significant increase in resorptions compared to the control group (8%). Gabapentin, on the other
hand, appears to mitigate the effects of ethanol because fetal exposure to gabapentin + ethanol
resulted in only 2% of fetuses partially or fully resorbed, similar to the control group.
Collectively, these results indicate that ethanol significantly alters fetal development and growth,
which was expected from prior studies. Remarkably, treatment with gabapentin was able to
block or mitigate the effects of ethanol on fetal resorptions, a measurement of fetal death.
Neither of the hyperpolarizing drugs was able to block the effects of ethanol on body weight or
body length.
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Figure 3.1. Fetal ethanol exposure affects fetal growth and development. (A) Quantification
of the average weight of fetuses at gestational day 17. (B) Quantification of fetal body length
(mm) at gestational day 17. (C) Percentage of fetuses that were affected by partial or full
resorptions at gestational day 17. In panels A and B, * indicates p<0.05, Fisher’s LSD posthoc
test after significant 1-way ANOVA. In panel C, * indicates p<0.05, Chi Square test.
Prenatal ethanol exposure alters fetal brain weight and brain morphology
Ethanol exposure during fetal development is known to affect the size and shape of the brain, as
well as neurobehaviors. We next examined fetal brain weight at GD 17; as expected, we
observed a significant decrease in brain weight in fetuses from the ethanol treated group (Figure
3.2A). Pups treated with lamotrigine + ethanol or gabapentin + ethanol also had decreased brain
weights compared to the control animals (Figure 3.2A), but these diminished brain weights were
not statistically significant, suggesting that the hyperpolarizing drugs may somewhat mitigate the
effect of ethanol on this parameter.
Next, we also conducted geometric morphometric evaluations on the brains using MorphoJ;
these tools allow us to evaluate the size and gross brain morphology in each treatment group. As
indicated by Figures 3.2B-E, we observed a noticeable change in brain size in the ethanol-treated
fetuses compared to the control group. The shape of the brain was also altered between these
groups; the ethanol treated fetal brains had a larger cerebrum than those in the control fetuses.
The effect of ethanol on brain size appears to be visibly rescued with exposure to lamotrigine;
these brains look similar in size to the control brains. However, the alteration of brain shape with
a larger cerebrum, as seen in the ethanol treated group, is observed in this group as well. In
contrast, fetuses from the gabapentin + ethanol treated group appear to have brains that look
similar to those collected from fetuses exposed only to ethanol, with a decrease in size and
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altered shape. These results suggest that no mitigation has taken place in gabapentin-treated
fetuses.
In conclusion, we observed a decrease in brain weight in the ethanol-treated group, with partial
mitigation by co-treatment with either lamotrigine or gabapentin. When examining the
morphology of the brains, ethanol tends to decrease the brain size and also alter the shape of the
brain, with an increase in relative size of the cerebrum. Although lamotrigine may mitigate the
effect of ethanol on the size of the brain (returning it to a normal size), the relative shape and size
of cerebrum continues to be altered in this treated group. Lastly, there seems to be no mitigation
on the effects of ethanol on the fetal brain by gabapentin.
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Figure 3.2. Effects of ethanol administration during pregnancy on fetal brain weight and
morphology. (A) Quantification of fetal brain weight among all treated groups. (B) Structural
depiction of brain morphology of the control group. (C) Structural depiction of brain morphology
in ethanol- treated animals. (D) Structural depiction of brain morphology in Lamotrigine + EtOH
treated animals. (E) Structural depiction of brain morphology in Gabapentin + EtOH treated
animals. In panel A, * indicates p<0.05, Fisher’s LSD posthoc test after significant 1-way
ANOVA.
Ethanol treatment alters duration of gestation, pregnancy-associated growth, and mortality
In addition to fetal outcomes, we also evaluated maternal outcomes during pregnancy. Ethanol
treatment in female dams on day 8 of pregnancy significantly increased the duration of
pregnancy compared to control dams (Figure 3.3A). Mice exposed to gabapentin + ethanol
follow the same trend with a significant increase in the length of gestation. With females treated
with both lamotrigine and ethanol, there was a trend (p-value = .084, Fisher’s LSD posthoc test)
for increased length of gestation. These results indicate that ethanol administration during early
pregnancy increases the length of gestation, with partial mediation of the effect by lamotrigine.
Another maternal outcome we evaluated was body weight gain in the dams throughout
pregnancy. There were no differences in weight gain throughout pregnancy in any of the treated
groups; dams typically doubled their weight from the beginning of pregnancy until the day that
they delivered their pups (parturition, see Figure 3.3B). Generally, in mice treated with ethanol,
we observed a modest decrease in weight the day after ethanol treatment, followed by a rebound
in body weight within two days of ethanol treatment (Figure 3.3C). Due to this trend, we
evaluated whether there were differences in post-ethanol rebound weight in animals who also
were administered hyperpolarizing drugs. There were no significant differences due to
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lamotrigine or gabapentin treatment on this outcome. These results indicate that hyperpolarizing
drugs do not provide protection from the effects of ethanol on body weight in pregnant female
mice.
In addition to weight rebound, we also observed increased mortality in dams following ethanol
treatment. Therefore, we next examined whether there were differences in deaths due to
treatment with hyperpolarizing drugs. Compared to control mice where no deaths occurred, there
was a significant increase in deaths in the group treated with ethanol only (20% mortality post
treatment, see Figure 3.3D). The same trend was observed in females administered the ethanol
that were exposed to gabapentin (17% mortality post-ethanol administration). Interestingly, there
were no observed deaths in females who received ethanol and were also exposed to lamotrigine.
Overall, these results indicate that ethanol poses a significant risk of death for dams during
pregnancy, and lamotrigine may act as a protective agent against this effect.

Ethanol treatment alters duration of gestation, pregnancy-associated growth, and mortality
In addition to assessing maternal deaths, we also examined other aspects of maternal-infant
health. Another component we analyzed during the neonatal period was maternal care, defined
by cleanliness of pups, placement of pups inside the nest versus outside, and the presence of
normal nursing behaviors. In a small number of litters, we observed that pups were not cared for
properly, were bruised and bitten, or were delivered and not properly cleaned. As indicated in
Figure 3E, using these broad criteria, there were no differences in observed maternal care deficits
across treatment groups. These results suggest that neither ethanol nor the hyperpolarizing drugs
increase deficits in maternal care.
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We also examined pup death at or near parturition and during the neonatal period (defined as the
first 10 days of life). As expected, we observed an increase in pup death at parturition due to
ethanol exposure (Figure 3.3F). Lamotrigine had no effect on the number of pup deaths at
parturition induced by ethanol exposure whereas gabapentin may partially mitigate the effects of
ethanol with decreased pup deaths at parturition.
During the neonatal period, we were surprised to find that the litters with the greatest number of
deaths were in the control group. There was a decrease in deaths during the neonatal period in
both the ethanol treatment group and the gabapentin + ethanol group. Pups in the lamotrigine +
ethanol treatment group, however, followed a similar trend as the controls, with increased pup
death in the neonatal period (Figure 3.3G). Collectively, these results suggest that ethanol
increases the risk of death in pups at or near parturition but not during the rest of the neonatal
period, and deaths at parturition are diminished with exposure to gabapentin.
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Figure 3.3 Effect of ethanol on maternal outcomes and death during pregnancy.
(A) Quantification of gestation length in treated groups. (B) Percentage of body weight gain
during pregnancy for female dams. (C) Quantification of weight rebound in dams post ethanol
administration. (D) Percentage of female dams who died after ethanol treatment on pregnancy
day 8 compared to controls (not administered ethanol). (E) Percentage of litters with maternal
care deficits during the first ten days after birth. Broadly defined, care deficits included mothers
with bruised or dirty pups, or pups that were not gathered in the nest. (F) Percentage of litters
with deaths in the neonatal period per treatment group. (G) Percentage of litters with death at
parturition per treatment group. In panel A, * indicates p<0.05, Fisher’s LSD posthoc test after
significant 1-way ANOVA. In panel D, * indicates p<0.05, Chi Square test.
Prenatal ethanol exposure affects pup growth and development during the neonatal period
From PND 1 to PND 10, we measured litter weight among all treatment groups to determine if
ethanol and/or the hyperpolarizing drugs induce any differences in pup growth. Litters were
allowed to nurse throughout the first 21 days of life without interventions such as litter culling.
Throughout most of the neonatal period, litters, regardless of treatment, had similar weights
(Figure 3.4A). However, on PND 10, differences in body weights between the treatment groups
were observed; litter weight for ethanol treated pups was significantly lower on PND 10
compared to control litters. To rule out that the differences in body weight were due to
differences in litter size, which is a risk factor for intrauterine growth restriction and neonatal
catch-up growth, we quantified litter size on PND1038 . No differences were observed in the
number of pups per litter on PND10 (Figure 3.4B). There were also no differences in the
male:female sex ratios based on treatment (data not shown).
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When we examined litters to determine if the presence of a single growth-restricted pup (e.g., a
“runt”) could be responsible for these lighter litter weights at PND10, we observed a modest
increase in the number of litters with runts in the ethanol-treated group (Figure 3.4C). Finally, at
PND14, we examined each pup individually to determine if their eyes were opening; on this day
of development, between 80-90% of pups normally have both eyes opened (10-20% have only
one eye, or both eyes, still sealed closed). In controls, we observed that an average of 17% of
pups in each litter had one or both eyes closed, but this increased to 45% in the ethanol-treated
litters (Figure 3.4D). This effect was mitigated by both lamotrigine and gabapentin.
Collectively, these results suggest that there are latent effects of alcohol exposure on pup weight,
consistent with modest growth restriction, and pup development, as measured by eye opening on
PND14. Both growth restriction and neonatal development delays may have been mitigated by
co-treatment with either lamotrigine or gabapentin.
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Figure 3.4. Ethanol disrupts neonatal growth but does not alter litter size or sex ratios.
(A) Growth curve of pup litter weight from PND 1 to PND 10. (B) Mean number of pups per
*

litter on PND10. (C) Number of litters with one or more runts. (D) Average number of pups in
each litter with one or both eyes closed on PND14
Prenatal ethanol exposure alters brain weight and size during the prepubertal period
On PND21, one male and one female were selected from each litter for tissue collections. During
necropsy, we collected and fixed pup brains for morphometric analyses to analyze the size and
shape of the brain.
Using MorphoJ, we analyzed the size of the left and right cerebrum as well as the size of the
cerebellum. Because we noted differences in body size at PND21 between male and female pups,
we separated the results by sex. As seen in Figure 3.5A-B, there were no significant differences
in the size of the cerebrum (left or right) for either sex based on prenatal treatment group.
However, prenatal ethanol exposure produced modest changes in the size of the cerebellum, with
statistically significant increases in females (Figure 3.5C). This effect was mitigated by
lamotrigine exposure, where the cerebellum size was comparable to the control group.
Gabapentin did not mitigate the effects of ethanol; gabapentin + ethanol treated female pup
brains exhibited a larger cerebellum compared to controls.
In addition to size of the brains, evaluated based on gross morphology, we also analyzed the
effect of ethanol and hyperpolarizing drugs on pup brain weight (Figure 3.5D). Once again, we
observed sex- specific effects with females affected most by ethanol treatment; brain weight
(normalized to body weight) was significantly decreased in females treated with ethanol.
Surprisingly, the effect of ethanol on female brain weight was mitigated by lamotrigine
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exposure. Gabapentin, on the other hand, appeared to aggravate the effects of ethanol on pup
brain weight; pups exposed to gabapentin + ethanol showed even more drastic decreases in brain
weight in comparison to control pups.
As previously described for fetal brains, we also used MorphoJ to conduct further geometric
morphometric analyses of the prepubertal brains; these approaches would allow us to look
beyond changes in size to determine if ethanol and/or hyperpolarizing drugs were also affecting
brain shape. Figure 3.5E depicts the shape of pup brains, separated by treatment, and there were
no obvious differences in the shape of the brains. Principal Component Analysis confirms that
there is low variability in the shape of the brains within and between the treatment groups
(Figure 5F). In conclusion, prenatal ethanol administration induces sex- specific effects on the
size of the cerebellum and brain weight, with females showing more drastic changes. Both of
these endpoints were mitigated fully by lamotrigine exposure but not changed by gabapentin
exposure.
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Figure 3.5. Effect of prenatal ethanol and hyperpolarizing drug treatment on brain size
and weight. (A) Size of the left cerebrum in PND 21 pup brains, separated by sex. (B) Size of
the right cerebrum in PND 21 pup brains, separated by sex. (C) Size of the cerebellum in PND
21 pup brains, separated by sex. (D) PND 21 pup brain weight, separated by sex. (E) Structural
depiction of brain morphology at PND 21, separated by treatment. (F) Principal component
analysis of PND 21 brain geometric morphometrics. In panels C and D, * indicates p<0.05,
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Fisher’s LSD posthoc test after significant 2-way ANOVA (sex and treatment as independent
variables).
Prenatal ethanol exposure alters locomotive behaviors in female mice prior to puberty
During the prepubertal stage, we conducted an open field behavior test to assess locomotion and
anxiety-like behaviors of the pups that may be affected by ethanol treatment. We observed that
prenatal exposure to ethanol alters locomotion in a sex- specific manner, with significant effects
seen only in male mice. During the 5-minute period in the open field, ethanol-treated males
displayed significant decreases in total distance travelled (Figure 3.6A), mean velocity (Figure
3.6B), and total time spent moving (Figure 3.6C). Lamotrigine and gabapentin did not mitigate
the effects of ethanol on either total distance travelled or mean velocity. Lamotrigine, however,
did mitigate the effects of ethanol on time spent moving, increasing this parameter to a similar
level as observed in the control group.
We also evaluated anxiety-relevant outcomes including the number of times the mice moved in
the center versus the border, and separated these results by sex. For number of times the animal
entered the center of the open field, we observed a decrease in ethanol-treated males, consistent
with lower anxiety-like behavior, but these results were not statistically significant (Figure
3.6D). For females, we observed a decrease in the number of times spent in the border with
ethanol exposure. Both exposure to lamotrigine and gabapentin with ethanol resulted in rescue of
this effect.
Interestingly, although females treated with ethanol tended to spend less time in the border, there
was no subsequent increase in time spent in the center, indicating that these mice were in the
periphery of the arena. The heatmaps shown in Figure 3.7 show that movement for mice was
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altered with ethanol exposure, as pups in the control group explored a greater area of the arena
compared to pups in the other treatment groups and this was independent of sex. The heatmaps
indicate that mice in ethanol treated groups, including those who were exposed to lamotrigine or
gabapentin, spent more time moving around in the border of the arena.

Figure 3.6. Ethanol decreases locomotion in male mice during an open field test. (A) Total
distance travelled by male mice in the 5-minute interval of the Open Field Test. (B) Mean
velocity of male mice during the Open Field Test. (C) Total time male mice spent moving during
the 5-minute duration of the Open Field Test. (D) (D)
Number of times male and female mice spent
in the center of the open field. (E) Number of times male and female mice spent in the border of
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the open field. In panels A, B and C, * indicates p<0.05, Fisher’s LSD posthoc test after
significant 1-way ANOVA. In panel D and E, * indicates p<0.05, Fisher’s LSD posthoc test after
significant 2-way ANOVA (sex and treatment as independent variables).

46

47

Figure 3.7. Heatmaps of movement of mice in the open field test during a 5- minute
interval, separated by treatment and sex. (A) Heatmaps for pups in control group, with
females on the left and males on the right. (B) Heatmaps for pups in the EtOH group, with
females on the left and males on the right. (C) Heatmaps for pups in the Lamotrigine + EtOH
group, with females on the left and males on the right. (D) Heatmaps for pups in the Gabapentin
+ EtOH group, with females on the left and males on the right.
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Discussion

The effects of numerous teratogens on fetal outcomes have been well established in prior studies
of both animal models and humans. Ethanol is perhaps one of the best studied teratogens, with its
effects on human development well documented. Fetal alcohol syndrome involves serious health
outcomes following gestational exposure to ethanol including physical malformations such as
decreased body weight, a flat nasal bridge, medical issues associated with vision and hearing
defects, and cognitive deficiencies related to learning and memory61-63 . The mouse has been
used as a laboratory model to study the teratogenic effects of ethanol for several decades, and
like the human, these effects occur across a continuum, with fetal death and gross morphological
defects at the more serious end, and more subtle effects on behavior and cognition at the other64 .
Like other teratogens, the effects of ethanol on the mouse fetus are dependent on the dose, route
of administration, and timing of administration65 . Importantly, another feature that is relevant to
the health outcomes observed is animal strain; CD-1 mice have been shown to develop all of the
relevant aspects of fetal alcohol syndrome. Based on several previous studies, we selected this
strain of mice, the applied dosage of 6 g/ kg of ethanol via intraperitoneal injection, and
administration on day 8 of gestation66,67.
As expected, we observed effects of ethanol on measures of fetal growth, fetal death, neonatal
death, juvenile brain parameters, and behavioral patterns (Table 4.1). Prior rodent studies have
indicated that ethanol exposure in the stages consistent with the first trimester of a human
pregnancy (GD 0 to GD 10) leads to intra-uterine growth reduction including smaller skull sizes
and smaller body sizes, and increased neonatal mortality13-15. We also observed additional effects
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on the ethanol-treated mothers including maternal mortality and length of gestation (Table 4.1).
To our knowledge, this is the first time an increase in gestation length (parturition on GD 20
instead of GD 19.5) has been documented in ethanol exposed dams in comparison to the
controls. Prior research found that the gestation length for mice is heavily determined by genetics
and inter-strain variability for timing of parturition is minimal68 . Therefore, we believe even this
small increase in gestation length is biologically significant; the increase of around 12 hours
between treatment groups suggests that ethanol treatment may have induced developmental
delays in the fetus, ultimately leading to a delay in parturition.
Table 4.1: Summary of outcomes, effects of ethanol, and mitigation by hyperpolarizing
drugs.
Outcome

Affected by ethanol?

Mitigated by

Mitigated by

lamotrigine?

gabapentin?

Pregnancy outcomes
Gestation length

YES

YES

NO

body weight gain

NO

N/A

N/A

dam death post-

YES

YES

NO

NO

N/A

N/A

YES

NO

YES

EtOH
litters with maternal
care deficits
Death in litter at
parturition
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Death in litter at

YES

YES

NO

YES

NO

NO

YES

NO

NO

YES

NO

YES

YES

YES

YES

YES

YES

NO

YES

YES

YES

# pups on PND 10

NO

N/A

N/A

% litters with runts

NO

N/A

N/A

YES

YES

YES

Pup brain weight

YES

YES

NO

Size of cerebellum

YES

YES

NO

neonatal period
Fetal growth and survival
Fetal body weight at
GD17
Fetal body length at
GD17
Resorptions at GD17
Fetal brain development
Fetal Brain Weight
Fetal Brain
Morphology
Neonatal outcomes
Litter weight at PND
10

Eye opening on
PND14
Pup brain
development
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Pup brain
NO

N/A

N/A

YES

NO

NO

Mean velocity

YES

NO

NO

Time spent moving

YES

YES

NO

# times in center (M)

NO

N/A

N/A

NO

N/A

N/A

NO

N/A

N/A

YES

YES

YES

morphology
Pup behavior
Total distance
travelled

# of times in center
(F)
# of times in border
(M)
# of times in border
(F)

A previous study conducted by our collaborators at Tufts University examined the effects of
exposures to nicotine, a known teratogen, on individual cells, organs, and cognitive function in
Xenopus tadpoles exposed during the first stages of development. Through their study, they
recognized that nicotine-induced teratogenesis involves disruption of endogenous voltage
membrane patterns which lead to alterations in gene expression, tissue/organ morphology, and
behavior11. Our collaborators also hypothesized that these teratogenic effects could be blocked or
mitigated by normalizing the bioelectrical environment of the developing embryo. They found
that molecular genetic manipulations to membrane voltage, such as overexpression of the ion
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channel HCN2, could rescue birth defects in Xenopus embryos. They showed that this rescue
occurred due to restoration of the membrane voltage potentials11.
Thus, we next examined whether hyperpolarizing agents were sufficient to mitigate the effects of
ethanol on CD- 1 mice. These proof-of-principle experiments were designed to determine if the
effects of membrane voltage normalization established by our collaborators in an aquatic species
extends to a mammalian model. Although future studies should examine molecular genetic
manipulations in mice, we first started with hyperpolarizing drugs that could be easily
administered, with low maternal toxicity previously documented.
Mitigation by either drug varied for all the outcomes that we evaluated. For Lamotrigine, we
observed no mitigation of effects of gestational ethanol exposure on fetal outcomes (i.e. body
weight, body length and resorptions) and no mitigation of effects on anxiety-like behaviors, as
measured with the open field test. With Gabapentin, we also did not see any mitigating effects of
the drug on fetal body weight or length, nor for any of the pup behavior outcomes. We also did
not observe any interaction of the drug with effects on pregnancy outcomes such as gestation
length or dam death after ethanol administration on GD 8.
Yet, remarkably, we did observe mitigation of other effects, and these varied between the two
hyperpolarizing drugs. While Gabapentin was not able to mitigate pregnancy outcomes, we saw
rescue of ethanol-induced effects by lamotrigine on two important pregnancy outcomes:
gestation length and dam death. We also saw mitigation of ethanol-induced effects by
lamotrigine on fetal and pup brain development; for gabapentin, the only ethanol-induced brain
effect that was rescued was fetal brain weight at GD 17.
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The differences in how the drugs interact with ethanol administration may be due to their mode
of action. Lamotrigine functions through blocking voltage- gated sodium channels, and, thereby,
inhibiting release of excitatory neurotransmitters; in contrast, gabapentin binds to voltage- gated
calcium channels and prevents depolarization through attenuation of calcium signaling69,70 .
Because these drugs operate by altering different voltage- gated channels and creating a cascade
of effects on different signaling molecules, their ability to rescue effects of ethanol may be
related to ethanol’s own interaction with the voltage-gated channels and signaling molecules.
More studies need to be conducted in order to understand the mechanism behind mitigation by
these drugs on endpoints of teratogenesis, and determine if hyperpolarizing – by any means – can
counter the effects of ethanol and other depolarizing teratogens.
Our study focused on the morphological and behavioral outcomes induced by ethanol and/ or
drug exposure but did not evaluate the mechanistic pathways from which these changes arose.
Future studies should evaluate the role of bioelectrical properties in embryonic development in
the mouse. In order to determine if hyperpolarization (via drugs or molecular genetic
manipulations) can counteract depolarizing teratogens such as ethanol, we will need to quantify
membrane potential in embryos, the response of these membrane potentials to ethanol exposure,
and the change in membrane potential when one of the two drugs is present. This could possibly
be evaluated with microscopy and membrane potential assay, where fluorescent reporter dyes
(like DiBAC or CC2-DMPE) indicate the membrane potential of fields of cells. In early
embryos, patch-clamp assays may also be useful.
A limitation of our study is also the inability to determine if the effects that these drugs have on
the various outcomes are due to their hyperpolarizing characteristics. As mentioned in Chapter 1,
both lamotrigine and gabapentin have off- target effects and our preliminary study also indicates
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some teratogenic effects of the drugs themselves. For example, it is possible that these drugs are
not acting via a bioelectrical mechanism, but instead are altering the maternal metabolism of
ethanol; this could explain why fewer dams experienced maternal mortality, if the circulating
concentrations of ethanol were disrupted by drug treatment.
We observed changes in brain morphology due to ethanol exposure with some mitigation by the
drugs. The next step would be to evaluate specific changes occurring in the brain; for example,
prior studies have shown that ethanol induces a decrease in neurons in the neocortex and alters
neocortical cell migration71 . Although we conducted histological analyses in the brains we
collected for this experiment, future studies including DiI treatments, which allow neuronal
synapses to be mapped within brain regions, may help provide further insight into the specific
brain nuclei impacted by ethanol exposure. In addition, more research is needed to understand
the changes in cerebellum that we observed: is there neuroapoptosis happening in the cerebellum
in response to ethanol? If so, through what pathway is this occurring and how might lamotrigine
impact this effect?
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Conclusions
Our study provides a preliminary, but compelling first step, to evaluate the effects of
hyperpolarizing agents on ethanol-induced teratogenic events. Our results provide an avenue for
additional research on these interactions. The mechanisms through which teratogens act and
induce changes in the developing organism are complex and may involve multiple molecular
pathways. Moreover, changes on the individual cellular level which may then alter cell
patterning and gene expression are understudied and need to be researched further. We found
that ethanol exposure affected pregnancy outcomes, maternal outcomes, and pup outcomes both
prenatally and postnatally. We also observed that lamotrigine and gabapentin did partially or
fully mitigate some effects of prenatal exposure; however, the mitigation of these drugs varied
from each other and in the degree to which they rescued the teratogenic events.
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CHAPTER 4
DISCUSSION AND CONCLUSIONS
Summary of Findings
The experiments described in this thesis had two distinct purposes: In Chapter 2, we evaluated
whether three hyperpolarizing drugs (lamotrigine, gabapentin, and ivermectin) induced
teratogenic events in CD-1 mice exposed throughout embryonic and fetal development. Some
prior studies concluded that these drugs could induce birth defects, while others have not
reported teratogenic effects39,72,73 . We found that all three drugs induced fetal malformations,
including effects on the limbs (gabapentin and lamotrigine) and the cranium (ivermectin and
lamotrigine). In Chapter 3, we asked whether two of these hyperpolarizing drugs, lamotrigine
and gabapentin, would exacerbate or attenuate the effects of ethanol, a known teratogenic agent
that depolarizes mammalian cells. In this chapter, we were able to: 1. Identify effects of ethanol
on both maternal and pup outcomes and 2. Conclude that both lamotrigine and gabapentin had
mitigating effects on some, but not all, of the endpoints that were evaluated.
Our study provides the proof-of-principle that hyperpolarizing drugs might be used to block or
reverse the effects of some environmental teratogens. Our findings serve as a jumping point for
future studies, which should examine genetic manipulations of bioelectrical properties in mice,
as well as mechanistic documentation of the effects of ethanol exposure on membrane potential
during different stages of embryonic development. Both the work conducted by our collaborators
at Tufts University and this project suggest that some effects of teratogens can be rescued
through manipulation of membrane voltage of embryonic cells11 .
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Beyond Teratogens: The Scope of Bioelectric Signaling
What are the other implications of this study? Prior research has indicated that both nicotine and
alcohol induce morphological and cognitive defects through alteration of bioelectric signaling,
leading to changes in cell behavior and cell function74,75. Studies specifically using live voltage
and pH reporter dyes have indicated that inhibiting voltage- regulating channels during
embryogenesis in Xenopus disrupts tissue and organ morphology, especially within the brain and
eye region9 . Bioelectric signaling is a characteristic of all cells in the body and the membrane
potential of these cells drive their actions and responses within the body76 . Although ion flux is
typically discussed in the context of rapid changes in membrane voltage (in neurons and
electrical cells of the heart, for example), stable and/or slow changes to the resting membrane
potential occurs within all cells of the body, and membrane voltage domains can be created and
propagated through sheets/groups of cells connected by gap junctions76,77 . Gap junctions allow
for communication within both adjacent and distant cells and the flux of ions through these
structures is involved in cell/tissue differentiation, control of cell size, and tissue/organ
patterning during embryogenesis3,78,79.
Development of molecular genetic tools has led to the discovery that changes in ion flux within
cells can also control their rate of proliferation and apoptosis76 . In addition to controlling some
aspects of cell behavior, changes in bioelectric signaling may also have impact on whole tissue
behavior. As mentioned before, experiments involving reporter dyes to document changes to
membrane voltage and pH, and molecular genetic reagents to manipulate to ion pumps and
channels during Xenopus embryogenesis, resulted in craniofacial malformations, disruptions to
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tail regeneration, and left-right patterning defects80-84 . These results indicate that ion flux has
broad influence on developmental patterning events9 .
Bioelectric signaling is important for other biological outcomes beyond embryonic development
and patterning. For example, cancer has been hypothesized to be a developmental disorder where
changes in signaling during embryogenesis and early development, deviating from the patterns
observed during normal cell and tissue pattering, can disrupt a cell’s normal function and
promote tumorigenesis85,86. In a study conducted by Lobikin et al., “instructor cells”, which are
cells that are able to promote a metastatic phenotype in neighboring neural crest cells, were
induced by an overall depolarization of membrane voltage during embryogenesis in Xenopus86.
Coupled with its potential to act as a non-invasive indicator for metastasis and tumorigenesis
makes the area of bioelectric signaling an area of interest for studying biological mechanisms of
cancer progression and for creation of novel therapeutics87-89 . Furthermore, there is a potential
role for bioelectricity in regenerative medicine. Within wound formation, the first changes at the
point of injury include a more negatively charged environment than normal76 . Once the wound
starts to heal itself, the environment then switches into a more positive one, indicating that
bioelectric signaling plays a role in cell behavior outside of development and embryogenesis76. If
there is potential to promote (by inducing regeneration in a normally not-regenerating body part),
or limit/inhibit uncontrolled cell growth (in the case of cancer) through changes in behavior of
ion pumps or channels, then therapies that are not solely gene therapies could be explored for
patients.
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Prevention or Intervention?: Ethical Considerations
Scientists and clinicians from a large number of fields, ranging from toxicology to embryology
to neuroscience, have contributed important knowledge about the effects of teratogens like
ethanol. In Chapter 1, we highlighted many of the known effects of fetal exposures to alcohol,
established in both human and animal models. Out of this discussion comes the ethical question
that now should be addressed by environmental health scientists: should society accept that
developing fetuses and infants are exposed to hazards, including preventable hazards, and rather
than limit exposures we should attempt to mitigate the hazardous effects of exposure through
other means? In other words, should we accept that some women will consume alcohol during
pregnancy, and develop therapies that can counteract the effects of ethanol, even if those
treatments also have risks?
Within public health, it is typically understood that prevention of a problem is a higher priority,
and is often more successful to minimize risks, compared to interventions or mitigations after a
problem has developed. While ethical considerations do need to be taken, there are other aspects
of teratogen exposure that should be addressed as well. For one, within the topic of alcohol
exposure, many pregnant women who may engage in binge- drinking behavior during their first
trimester of pregnancy may not be aware that they are pregnant. This allows for a window of
time where reckless behavior may take place without knowledge of pregnancy. Therefore, by the
time that awareness of pregnancy does take place, there has potentially already been an impact
on the embryo or fetus. Thus, examining potential regenerative therapy may be a beneficial
avenue to reduce the many birth defects that we see among newborns today in the United States.
On the other side of this ethical argument is the production of environmental pollutants that can
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act as teratogens. In these cases, pregnant women are likely exposed without their knowledge or
consent, and not due to reckless behaviors. Should industries be allowed to pollute environments,
and the bodies of pregnant women, and then sell these same women a pharmaceutical treatment
to counteract the effects of their original pollutant? This seems like an obvious case where
primary prevention, protecting pregnant women from exposure to environmental teratogens, is
the best choice.
Nonetheless, as described before, the potential of bioelectric signaling extend beyond birth
defects and into creation of novel therapeutics. Though the study of bioelectric signaling has
been ongoing for decades, our understanding of the extent to which ion flux modulates cell
behavior, especially with uncontrolled cell growth, remains limited. Through additional studies,
we will be able to further our biological understanding of individual cell signaling and alterations
that may be caused by endogenous and exogenous changes.
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